CD39 mediated regulation of Th17-cell effector function is impaired in juvenile autoimmune liver disease

Journal of Autoimmunity - Tập 72 - Trang 102-112 - 2016
Rodrigo Liberal1,2, Charlotte R. Grant1, Yun Ma1, Eva Csizmadia3, Zhenghui Gordon Jiang3, Michael A. Heneghan1, Eric U. Yee4, Giorgina Mieli-Vergani1,5, Diego Vergani1, Simon C. Robson3, Maria Serena Longhi1,3
1Department of Liver Studies, Division of Transplantation Immunology & Mucosal Biology, MRC Centre for Transplantation, King’s College London, Faculty of Life Sciences & Medicine, London, UK
2Gastroenterology Department, Centro Hospitalar São João, Faculty of Medicine of the University of Porto, Porto, Portugal
3Division of Gastroenterology, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard University, Boston, USA
4Department of Pathology, Beth Israel Deaconess Medical Center, Boston, USA
5Paediatric Liver, GI & Nutrition Centre, King’s College London, Faculty of Life Sciences & Medicine, London, UK

Tài liệu tham khảo

Miossec, 2009, Interleukin-17 and type 17 helper T cells, N. Engl. J. Med., 361, 888, 10.1056/NEJMra0707449 Korn, 2009, IL-17 and Th17 cells, Annu. Rev. Immunol., 27, 485, 10.1146/annurev.immunol.021908.132710 Yang, 2008, T helper 17 lineage differentiation is programmed by orphan nuclear receptors ROR alpha and ROR gamma, Immunity, 28, 29, 10.1016/j.immuni.2007.11.016 Yang, 2007, STAT3 regulates cytokine-mediated generation of inflammatory helper T cells, J. Biol. Chem., 282, 9358, 10.1074/jbc.C600321200 Brustle, 2007, The development of inflammatory T(H)-17 cells requires interferon-regulatory factor 4, Nat. Immunol., 8, 958, 10.1038/ni1500 Zhang, 2008, Interactions among the transcription factors Runx1, RORgammat and Foxp3 regulate the differentiation of interleukin 17-producing T cells, Nat. Immunol., 9, 1297, 10.1038/ni.1663 Kirkham, 2006, Synovial membrane cytokine expression is predictive of joint damage progression in rheumatoid arthritis: a two-year prospective study (the DAMAGE study cohort), Arthritis Rheum., 54, 1122, 10.1002/art.21749 Krueger, 2007, A human interleukin-12/23 monoclonal antibody for the treatment of psoriasis, N. Engl. J. Med., 356, 580, 10.1056/NEJMoa062382 Matusevicius, 1999, Interleukin-17 mRNA expression in blood and CSF mononuclear cells is augmented in multiple sclerosis, Mult. Scler., 5, 101, 10.1177/135245859900500206 Duerr, 2006, A genome-wide association study identifies IL23R as an inflammatory bowel disease gene, Science, 314, 1461, 10.1126/science.1135245 Zhao, 2011, Interleukin-17 contributes to the pathogenesis of autoimmune hepatitis through inducing hepatic interleukin-6 expression, PloS One, 6, e18909, 10.1371/journal.pone.0018909 Gregorio, 2001, Autoimmune hepatitis/sclerosing cholangitis overlap syndrome in childhood: a 16-year prospective study, Hepatology, 33, 544, 10.1053/jhep.2001.22131 Longhi, 2009, Vigorous activation of monocytes in juvenile autoimmune liver disease escapes the control of regulatory T-cells, Hepatology, 50, 130, 10.1002/hep.22914 Deaglio, 2007, Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression, J. Exp. Med., 204, 1257, 10.1084/jem.20062512 Deaglio, 2011, Ectonucleotidases as regulators of purinergic signaling in thrombosis, inflammation, and immunity, Adv. Pharmacol., 61, 301, 10.1016/B978-0-12-385526-8.00010-2 Longhi, 2014, Characterization of human CD39+ Th17 cells with suppressor activity and modulation in inflammatory bowel disease, PloS One, 9, e87956, 10.1371/journal.pone.0087956 Grant, 2014, Dysfunctional CD39(POS) regulatory T cells and aberrant control of T-helper type 17 cells in autoimmune hepatitis, Hepatology, 59, 1007, 10.1002/hep.26583 Longhi, 2006, Functional study of CD4+CD25+ regulatory T cells in health and autoimmune hepatitis, J. Immunol., 176, 4484, 10.4049/jimmunol.176.7.4484 Longhi, 2004, Impairment of CD4(+)CD25(+) regulatory T-cells in autoimmune liver disease, J. Hepatol., 41, 31, 10.1016/j.jhep.2004.03.008 Chen, 2006, ATP release guides neutrophil chemotaxis via P2Y2 and A3 receptors, Science, 314, 1792, 10.1126/science.1132559 Beldi, 2008, Natural killer T cell dysfunction in CD39-null mice protects against concanavalin A-induced hepatitis, Hepatology, 48, 841, 10.1002/hep.22401 Bai, 2014, CD39 and CD161 modulate Th17 responses in Crohn’s disease, J. Immunol., 193, 3366, 10.4049/jimmunol.1400346 Bengsch, 2012, Human Th17 cells express high levels of enzymatically active dipeptidylpeptidase IV (CD26), J. Immunol., 188, 5438, 10.4049/jimmunol.1103801 Esplugues, 2011, Control of TH17 cells occurs in the small intestine, Nature, 475, 514, 10.1038/nature10228 Gagliani, 2015, Th17 cells transdifferentiate into regulatory T cells during resolution of inflammation, Nature, 523, 221, 10.1038/nature14452 Liao, 2010, cAMP/CREB-mediated transcriptional regulation of ectonucleoside triphosphate diphosphohydrolase 1 (CD39) expression, J. Biol. Chem., 285, 14791, 10.1074/jbc.M110.116905